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ABSTRACT 
Oral squamous cell carcinoma (OSCC) is the sixth most frequently occurring 
cancer worldwide. In the US approximately 50,000 new cases are diagnosed per 
year, representing 90% of all the cancer cases of the oral cavity. When oral 
squamous cell carcinoma is diagnosed it is often at an advanced stage.  Novel 
technology to enhance early detection of oral squamous cell carcinoma could 
lead to early, less intensive treatments that increase patient survivorship as well 
reduce toxicity. 
In recent years Optical Coherence Tomography (OCT), a new non-ionizing, non-
invasive method, has been utilized to visualize and diagnose malignant lesions in 
diverse fields such as Ophthalmology, Gastroenterology, and Dermatology. 
The objective of this current research was to demonstrate the efficacy of OCT for 
diagnosing potentially malignant oral mucosal lesions of the tongue. Forty nine 
mice were used in this study: 39 mice were treated with the carcinogen 4-
nitroquinoline 1-oxide (4NQO) for up to 13 weeks, and 10 mice served as 
untreated controls. After specified treatment times, the posterior regions of the 
tongues were evaluated with the use of OCT and histopathologic analyses. 
Images of the histopathological sections were used as the gold standard, and 
compared with the OCT images to verify the accuracy of the OCT diagnoses. 
Two examiners evaluated clinical images and OCT images of the 49 specimens, 
which were compared with the histological results. This comparison 
demonstrated that clinicians were more accurate in the clinical identification of 
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the normal aspect of the tongues, however some differences were found in the 
results of the clinical evaluation of the treated group with the histological results. 
The analyses of control group OCT images compared with the histological results 
were moderately accurate as were those obtained with the clinical evaluation. 
However, the comparison of results of the evaluation with the OCT of the treated 
group and the histological analysis were different between the examiners and 
were not correctly classified based on the histological results. 
Comparison of these results demonstrated that clinical evaluation is important in 
the identification of possible lesions in the oral cavity, however the criteria and 
results may vary between dentists. OCT may become a useful imaging 
technique, in which images resembling the microstructural changes occurring in 
the epithelium of the oral cavity will guide the specialist to the precise area to be 
evaluated with the histopathological analysis. This study demonstrated 
differences between both examiners and variations in their consistency to 
evaluate the OCT images. Despite that OCT is a high resolution imaging 
technique in which images are similar to a low power microscope (4x), it is 
important that the clinician is familiar with the normal appearance and changes 
expected to be present in possible lesions that will be visualized in the OCT 
images and histological sections, to avoid false positive or false negatives.  
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ORAL CANCER 
One of the major public health problems in the United States and many other 
countries of the world is cancer; approximately one in four deaths in the United 
States is related to cancer 1. Oral cancer is the eighth most-common cancer 
among white males and the sixth most common cancer among Afro-American 
males in the United States. In other regions of the world,  especially in South-
Central Asia, head and neck cancers are the most common malignancies found 
in men. In the U.S., approximately 9,000 deaths per year are a consequence of 
oral cancer, making it more deadly than breast cancer, cervical cancer and 
prostate cancer. It has been estimated that one person is killed, every hour, 
every day by oral cancer 2, 3.  
Oral cancer is defined as any cancerous tissue growth located in the mouth. It 
may arise as a primary lesion originating in any of the oral tissues or by 
metastasis from a distant site of origin. Squamous cell carcinoma, which 
develops from the stratified squamous epithelium that lines the mouth and 
pharynx, is the most common cancer diagnosed of all the different types of 
cancer that may be found in the oral cavity 4-6.  
Squamous Cell Carcinoma (SCC) of the oral region is the sixth most common 
malignancy worldwide 4. Approximately 50,000 new cases of squamous cell 
carcinoma of the head and neck are diagnosed each year in the United States. 
According to the American Cancer Society, in 2013 the total estimated number  
of new cases of cancer in all anatomic sites was 1,660,290, and 41,380 was the 
estimated number of new cases of oral and pharynx cancer, representing 2.5% 
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of all the new cases of all sites in the body 7. Cancers of the lips, tongue, floor of 
the mouth, palate, gingiva, alveolar mucosa, buccal mucosa, and oropharynx will 
account for approximately 30,000 of these cases 5. According to Jemal et al. 48 
% of all cancers located in the head and neck are located in the oral cavity and 
90% of these are OSCC 8. In the past, squamous cell carcinoma of the oral cavity 
was primarily found in male patients aged 60 years and older with an extensive 
history of tobacco smoking, alcohol consumption and poor oral hygiene, which 
may act additively or synergistically on a genetically susceptible individual. 
However, some studies have shown increased incidence of oral SCC (OSCC) 
among young patients, under 40 years of age,  being more frequent in women 
with no history of tobacco smoking.  Other agents that may contribute to the rise 
in the number of cases of oral cancer are various forms of drug abuse, 
environmental factors, diet  and  the human papilloma virus (HPV), although the 
HPV is not considered to be a significant risk factor of the anterior two thirds of 
the tongue or the remaining oral cavity 3, 9-12.  
Approximately 50-55 percent of patients with oral cancer survive beyond five 
years; this rate has not improved during the last 50 years. When the oral cancer 
is localized at diagnosis the five year survival rate is approximately 75%, but in 
general this disease is diagnosed in stages 3 and 4 with lymph node  metastasis, 
reducing the probability of five-year  survival to 26.5% 3, 12, 13. 
The tongue is the most common site for oral cancer in both American men and 
women. This is also true of developed countries, however, in some developing 
countries, site prevalences may differ owing to culture-specific habits, for 
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example, nasopharyngeal cancer in Southeast Asia and buccal cancer in India 
are the most common oral and pharyngeal sites 5. Patients with oral tongue 
squamous cell carcinoma have a significantly worse prognosis than those with 
similar lesions of the oropharynx, larynx, hypopharynx and other sites of the oral 
cavity 4. The tongue includes a rich lymphatic network and a complex structure of 
muscles that make it the site most frequently associated with cervical metastasis 
compared to cancer of other sites in the oral cavity 10. 
Other common areas of oral cancer are: floor of the mouth, lip mucosa, 
retromolar gingiva, hard palate, buccal mucosa, lower and upper alveolar ridge. 
But cancers that develop in the tongue, floor of the mouth and lip mucosa 
represent more than 70% of all oral cancers 11. 
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POTENTIALLY MALIGNANT LESIONS 
At an early stage tongue OSCC is typically asymptomatic, making early 
diagnosis challenging 14. Therefore, clinical evaluation and possibly soft tissue 
imaging are the key methods for early identification and diagnosis of oral tongue 
squamous cell carcinoma. It is vitally important to recognize clinical signs and 
symptoms suggestive of oral squamous cell carcinoma at an early stage. These 
include  oral ulceration (non-healing), raised, everted, exophytic and indurated 
lesions, abnormal swellings, loss of tongue mobility, dysarthria, otalgia, 
cauliflower-like or warty growths, abnormal localized tooth mobility, non-healing 
tooth sockets, color changes in mucosa (red, white or speckled patches), 
erosive, raw mucosal patches, reduced or altered orofacial sensation 15. One of 
the greatest challenges that the dentist has is the dilemma to predict which of 
these lesions will progress to neoplasia, like the most frequent in the oral cavity, 
oral squamous cell carcinoma. Nevertheless, the biological relevance of benign 
and malignant lesions may not be distinguishable on the basis of their clinical 
appearance  12, 16. 
Dentists must be alert to the presence of subtle lesions that could be considered 
as premalignant and early stage malignant lesions. The World Health 
Organization defines premalignant lesions as morphologically altered tissue in 
which cancer is more likely to occur than in its apparently  normal counterpart. 
The most common lesions to be considered as potentially malignant lesions in 
the oral cavity are oral leukoplakia and oral erythroplakia. Other lesions to be 
considered as potentially malignant are reverse smoker’s palate, oral submucous 
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fibrosis and tobacco pouch keratosis 16, 17.  Clinicians should focus their attention 
on high risk sites where 90% of premalignant lesions arise; these are the floor of 
the mouth, ventrolateral aspect of tongue and soft palate 18.  
Leukoplakia is defined as a white patch or plaque that cannot be characterized 
clinically or pathologically as any other disease; the most common sites are 
buccal mucosa, alveolar mucosa and lower lip. Lesions that arise  on the floor of 
the mouth, lateral tongue and lower lip are most likely to show dysplastic or 
malignant changes and are considered high risk sites 17. Any leukoplakia that 
persists more than 10-14 days after conservative treatment should be considered 
as a potentially premalignant condition 19. 
Erythroplakia is defined as lesions of the oral mucosa that present as red areas 
and cannot be diagnosed as any other definable lesion. This lesion is uncommon 
compared with leukoplakia, and is found predominantly in middle aged and 
elderly people, with predilection for soft palate, buccal mucosa, tonsillar pillars 
and floor of the mouth. Some differences in location were found depending on 
gender. In men the most commonly affected site is the floor of the mouth, 
followed by the retromolar trigone, while in women erythroplakia is more common 
in the mandibular alveolar mucosa, mandibular gingiva and mandibular vestibule. 
Oral erythroplakia has the highest risk for malignant transformation compared 
with other premalignant lesions 17, 19. 
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DIAGNOSTIC METHODS 
Dentists utilize a variety of aids to diagnose oral precancerous and cancerous 
lesions. As with any test, proper case selection and correct performance of the 
test itself are critical to the sensitivity and specificity of its result. Some of these 
aids are: brush cytology (brush biopsy), tissue fluorescence, and toluidine blue 
staining. Some techniques utilized by specialists are: punch biopsy, scalpel 
biopsy, fine-needle aspiration cytology and sentinel node biopsy 19.  
Imaging techniques used to detect squamous cell carcinoma include plain 
radiography, computed tomography, magnetic resonance imaging and molecular 
imaging 18, 20, 21.  These imaging techniques are used to define the borders of the 
affected tissues (bone or soft tissue), the presence of internal contents in the 
lesion, regional lymphatic spread and the effects on adjacent tissues (expansion, 
remodeling, displacement, destruction). OSCC is difficult to diagnose in an early 
stage because the malignant changes are confined to the soft tissues. Most oral 
lesions are benign, but many have an appearance that may be confused with a 
malignant lesion, and some previously considered benign are now classified as 
premalignant because they have been statistically correlated with subsequent 
cancerous changes. Conversely, some malignant lesions seen in an early stage 
may be mistaken for a benign change. Any oral lesion that does not regress 
spontaneously or respond to the usual therapeutic measures should be 
considered potentially malignant until histologically shown to be benign 20, 22.  
Recently, Optical Coherence Tomography (OCT) has been implemented in 
dermatology and oncology to determine the presence of soft tissue lesions 23. 
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OCT  is a noninvasive diagnostic imaging modality with a high resolution that can 
give near histologic images with a safe broadband light source.  This imaging 
technique measures backscattered light generated from an infrared light source 
directed at the tissues being examined 24. Broadband laser light waves are 
emitted from a source and directed toward a beam splitter. One wave is sent 
toward a reference mirror with a known path length and the other toward the 
tissue sample. After the 2 beams reflect off the reference mirror and the tissue 
surfaces at varying depths in the sample, the reflected light is directed back 
toward the beam splitter, where the waves are recombined and read with a photo 
detector 25 (Fig. 1). OCT is the optical equivalent of ultrasound, using light 
instead of sound waves; it is a noninvasive and nondestructive method for 
imaging the microstructural detail of oral tissue in situ. Resolution up to 1-2 µm 
can be achieved, being 100-250 times greater than high-resolution ultrasound 26. 
It is capable of evaluating the health of hard and soft tissue by providing a cross-
sectional “optical biopsy” of tissue up to 3 mm in depth from the surface. The 
resultant images have an axial resolution of 1–10 µm, capturing structural details 
without the use of ionizing radiation and not possible with conventional x-ray 
imaging technologies 27. OCT is considered to be an optical “biopsy” by some 
authors because the image resembles the architecture observed in histology 26, 
27. For this technique to become clinically interpretable and relevant, the 
structures visualized must be correlated with the corresponding tissue 
microstructures 28.  
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The resolution of OCT permits in vivo noninvasive imaging of the macroscopic 
characteristics of epithelial and sub-epithelial structures including: depth and 
thickness, peripheral margins, and  potential histopathological appearance 29. 
OCT has been used to detect soft tissue malignant lesions in the oral cavity in a 
small number of studies but less frequently than with other areas such as 
ophthalmology, gastroenterology, urology and gynecology 30-33.  Current 
identification and diagnosis of potentially malignant and malignant oral mucosal 
lesions rely upon histologic and cytologic examination performed by a pathologist 
after suspicious tissue is biopsied. These methods represent the gold standard 
for cancer diagnosis.  However, they have some limitations, including the 
invasive nature of the biopsy, cost of the procedure, and typically two-three days 
Fig. 1  Diagram of the Optical Coherence Tomography based on: 
http://www.answers.com/topic/optical-coherence-tomography and  
In Vivo Optical Coherence Tomography for the Diagnosis of Oral Malignancy,  Wilder-
Smith et al, Lasers in Surgery and Medicine 35:269–275 (2004) 
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from time of biopsy to obtaining the histopathologic results.   Importantly, 
diagnostic interpretation of the tissue sample may vary among pathologists 29, 34.  
Additionally OSCC may not be detected until clinically advanced; subtle oral 
mucosal lesions may be overlooked by the clinician during visual inspection of 
the tissue 35.  Early malignant changes are still overlooked using conventional 
oral examination; an example of this is dysplasia that may be found in “clinically 
normal mucosa” 36. A recent meta-analysis reported 93% sensitivity for 
conventional oral examination, while specificity was only 31% 36. Recently some 
devices such as  VELscope 36, 37, Identafi 36, 38, and Narrow Band Imaging (NBI) 
36, 39, have been used to improve the evaluation of the oral mucosa to identify 
potential malignant lesions. Nevertheless, the differentiation of low and high risk 
lesions using some of these devices remains undetermined, with false positives 
obtained in some cases. These devices may affect the lesion’s appearance in 
terms of brightness, texture and delineation of the margins but they have not 
been shown to enhance the ability to identify potentially malignant lesions, 
especially those that are not visible under normal operatory lighting. Early-stage 
lesions often are asymptomatic and may mimic other conditions, whereas others 
may not be readily evident in routine examination. Also, because malignant and 
benign lesions may not be clinically distinguishable, the clinician cannot predict 
the biological relevance of lesions on the basis of their physical features alone 12. 
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OBJECTIVES 
The objective of this study is to demonstrate the efficacy of Optical Coherence 
Tomography to diagnose potentially malignant oral mucosal lesions of the 
tongue. 
 
HYPOTHESIS 
OCT image findings in potentially malignant oral mucosal lesions of the tongue 
are comparable to histopathologic findings. 
 
SPECIFIC AIMS  
1) To induce potential oral tongue SCC in mice using the carcinogen 4-
nitroquinoline 1-oxide;  
2) Obtain OCT images of the tongue lesions and compare them with 
histopathological sections of the lesions; and  
3) Determine quantitatively the correlation between OCT and histopathological 
images for specific structural parameters. 
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MATERIALS AND METHODS 
Study Design:  
All experimental procedures were performed at the University of Connecticut 
Health Center in complete concordance with the guidelines of an approved 
protocol (ACC# 100776-1016) for animal experimentation and in compliance with 
the guidelines set forth in the Guide for Care and Use of Laboratory Animals. 
Forty nine female C57BL/6J mice, 7 weeks-old, were used for this study, 10 as a 
control group and 39 with induced oral tongue squamous cell carcinoma. A total 
of fifty mice were received to start this project, but the first day of the experiment 
one mouse died, finishing with a total of 49 mice. The animals were acquired 
from Jackson Laboratory, Bar Harbor, Maine, United States of America. The 
OCT instrument that was used for this study was donated by Axsun 
Technologies, Inc. (Axsun Technologies, Inc., Billerica, MA)  to the Section of 
Oral and Maxillofacial Radiology of the School of Dental Medicine, University of 
Connecticut. This device is used for research specifically in the area of dentistry. 
 
Inducing Potentially Malignant Lesions in the Oral Cavity 
After 6 days of acclimation to their surroundings and a 12-hour light/dark cycle, 
mice were randomly placed in 1 of 10 groups, each group with a total of 5 mice 
except one group that had 4 mice. The first two groups with ten mice in total 
comprised the control group and the remaining 39 mice were treated with the 
carcinogen agent (See experimental timeline, Fig. 2.). The mice were maintained 
 11 
on standard rodent chow and water ad libitum, under normal laboratory 
conditions in the Center for Comparative Medicine, UCHC, in Room LB033C. 
The first day of the experiment, a solution consisting of distilled water with 100 
p.p.m. 4-nitroquinoline 1-oxide (4NQO) was provided to the test group to 
chemically induce potentially malignant mucosal lesions of the tongue. The 
4NQO is water-soluble and can be administered orally in drinking water. (The 
4NQO was acquired through Sigma- Aldrich, St. Louis, MO.) A fresh batch of 
water was prepared every week for each of the first to thirteenth week of 
carcinogen treatment. The mice drank this water with dilute 4NQO for up to 
thirteen successive weeks. Control mice received water without any additive. The 
level in the water bottles was monitored two times per week. 
 
 
 
 
 
 
 
 
Figure 2: Experimental Timeline 
 
Tanaka states that this carcinogenic agent produces all the stages of oral 
carcinogenesis with similar histological appearance and molecular changes that 
are observed in the human system 40. The 4NQO is a synthetic carcinogen 
derivative of a quinoline,  is soluble in water and sensitive to high temperature 
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and light (the 4NQO solution was stored in a brown glass bottle and brown glass 
water bottles were used with the mouse cages). One of the advantages of this 
carcinogen agent is that it is capable of inducing sequentially the different phases 
of carcinogenesis (hyperplasia, dysplasia, severe dysplasia, carcinoma in situ 
and OSSC) 41. The lesions obtained with the use of the 4NQO appear similar to 
damage imposed by other carcinogens present in tobacco, which is a major risk 
factor for oral cancer 42. 
The 4NQO is a powerful carcinogen that may act in several organs, and it can 
specifically induce tongue SCC when it is applied in low concentrations via 
drinking water 43. This potent mutagen and carcinogen, after metabolic activation, 
binds to DNA producing three main adducts: two on guanine (dGuo-N2-AQO, 
dGuo-C8-AQO) and one on adenine (dAdo-N6-AQO) 44. The 4NQO induces 
histological as well as molecular changes similar to those observed in human 
oral carcinogenesis. 4NQO has been used for the induction of oral cancer 
including dorsal and ventral tongue, palate and aerodigestive tract.  
 
Wellness Monitoring and Euthanasia 
 Depending on the group to which the mice were randomly assigned, they were 
exposed to 4NQO added to the drinking water or no treatment at all. In order to 
monitor the food and water intake, and the appearance and activity of the mice 
during the experiment, the mice were observed twice per week and weighed 
once per week, and these data were recorded in an Excel spreadsheet. In 
general, the mice gained or maintained their weight; a few treated mice lost a 
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small amount of weight, not more than 10% of body weight (between 0.5-1 g), 
over the full course of the experiment. Although both groups gained weight 
during the course of the experiment, the mice in the treated group did not gain as 
much as the ones in the control group. When the mice arrived at the Center for 
Comparative Medicine at UCHC, the mean weight was 18.70 g. Their weight 
increased progressively  until the 14th week, when the experiment finished; the 
mean weight of the two last mice of the control group was 23.95 g compared to 
the mean of the last 10 mice of the treated group of 20.40 g (Fig. 3). 
The first day of the experiment two mice of the control group were 
euthanized by CO2 inhalation. Subsequently, starting on the fourth week 
and every three weeks thereafter,  2 mice of the control group and 10 of 
the treated group were sacrificed using the same method of CO2 
0
6.25
12.5
18.75
25
31.25
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Mean Control Mean Treated
Fig. 3 Comparison of the body weight for the 
mice in control group vs Treated group 
Weight
 
Week 
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inhalation followed by cardiac transsection. The last 2 control mice and the 
last 10 treated mice were euthanized on the fourteenth week.  
Obtaining OCT Images and Histological Sections: 
After euthanasia, the tongues of the mice were excised and placed in a container 
with cold Phosphate Buffered Saline (PBS) identified with the number of the 
respective specimen. In general the location of the excision was at the posterior 
aspect of the throat. 
After excision of the tongues a clinical evaluation was performed to evaluate any 
macroscopic changes, the tongues were photographed  using a Canon camera 
EOS 60D with a Canon 28-135 IS lens, and the images were saved as RAW 
images. 
The posterior region of each tongue was scanned, using the OCT (Axsun 
Technologies, Inc), as many times as necessary to completely scan the area of 
its dorsum and ventral aspect. The images obtained from the scan were saved 
as TIFF images. To standardize the scan procedure, the tongues were placed in 
the middle portion of a round plastic device, the scanner was positioned in a 
perpendicular position to the table where the specimen was located; the same 
procedure was used to scan all 49 tongues. Once the tongues were scanned 
using the OCT they were fixed in 10% buffered formalin.   
The fixed tongues were sent to the Section of Oral and Maxillofacial Pathology to 
proceed with  a histological study of each specimen. The tongues were 
embedded in paraffin and the histological sections were stained with hematoxylin 
and eosin and coverslipped. The sections were scanned into the Aperio virtual 
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microscope system in the Faculty Instructional Technology Service, UCHC, using 
either the 20X or 40X objective lens. The sections were histologically evaluated 
in the same orientation as the OCT was previously performed.   
Image Analysis:  
Images obtained by OCT were coded and analyzed by a radiologist at the 
Section  of Oral and Maxillofacial Radiology at the University of Connecticut 
School of Dental Medicine. The Section of Oral and Maxillofacial Pathology 
provided histopathologic evaluations of the tongue sections. The criteria  used for 
the evaluations were based on the histological changes visualized in the different 
sections, such as: hyperkeratinization,  changes of the filiform papillae, increased 
thickness of the stratified squamous epithelium and changes of the basement 
membrane. According to these, the sections were categorized as: Normal, 
Hyperkeratosis, Hyperkeratosis with maturational disturbance and Maturational 
disturbance. A radiologist and pathologist evaluated the clinical images of the 
different tongues. The criteria to evaluate the tongues were based on the clinical 
appearance, color of the dorsum and ventral aspect of the tongues and the 
presence of any potential lesion such as leukoplakia or erythroplakia. According 
to these, the tongues were classified as: Normal, that included all tongues with 
pink appearance, smooth surface and no lesions on  their dorsal, ventral or 
lateral aspects, possible lesion was used when the evaluators considered that 
the tongues did not have a normal appearance but were not sure of the presence 
of an entity affecting the tongues, and the final category was lesion, that included 
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changes of the appearance of the tongue and presence of probable 
hyperkeratosis or other lesions such as leukoplakia or erythroplakia.  
The OCT images of the posterior tongue were evaluated using the following 
criteria: changes in the keratinized layer, changes in the thickness of the 
keratinized layer, in the thickness of the stratified squamous epithelial layer and 
changes observed in the basement membrane. The areas to be evaluated were 
the posterior, middle and tip of each tongue. According to the changes that were 
visualized the tongues were classified as Normal, when no changes were noted, 
possible lesion, when some changes were noted but the evaluators were not 
sure of the presence of a lesion, and the final option was lesion, that included 
significant changes noted by the evaluators (Fig. 4).  The evaluation of the OCT 
images was repeated by the same evaluators one week after the first evaluation 
was done.  
 
 
 
 
 
 
 
 
 
a                                                                     b 
 
 
 
 
 
 
 
 
 
                                 c Fig. 4 Histological (panels a and b) and OCT images (panel c) of the middle portion of normal mouse tongue.  Scale bars = 600 µm in (a) and 200 µm in (b). 
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The clinical images and the OCT images were presented in a Keynote slide show 
(Apple, Cupertino, CA).  The first four slides showed the normal aspect of the 
tongues, clinically and OCT images as well; after these four slides, the different 
clinical images and OCT sections were presented in a random order. For the 
second evaluation of the OCT images the order was changed to avoid bias with 
the previous results. The results obtained in both the clinical and OCT 
evaluations were compared with the histological classification determined by an 
oral pathologist, which was used as the gold standard.  
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RESULTS 
All the mice except one were included in the study. The one animal excluded 
from analysis died on the first day of the experiment. All mice included in the 
study remained in apparent healthy condition and had a slight increase in body 
weight (Fig. 3). 
Clinical evaluation 
Forty nine mice were used in this experiment, 10 of these were randomly 
selected for the control group and the remaining 39 mice were included in 
the treated group. The majority of the clinical changes noted in the treated 
group occurred on the dorsum of the tongue with the exception of one 
specimen that presented a verrucous appearing lesion on its ventral 
aspect (Fig. 5).  
 
 
 
 
 
 
 
 
 
 
 Fig 5. Comparison of clinical images: a) Normal appearance of mice with no treatment sacrificed in week 14 . Fig. b,c and d. Tongues of mice receiving 4NQO dissolved in drinking water and sacrificed at weeks 8, 11 and 14, respectively. Note the verrucous lesion in ventral aspect of the tongue (d).   
a                                                b                                  
c                                                                       d 
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 During the clinical evaluation of the untreated tongues, evaluator 1 
classified 8 of these as normal and 2 with a possible lesion, while 
evaluator 2 considered that 6 of 10 were normal, 3 with a possible lesion 
and 1 was classified with a lesion (Fig. 6). 
 
 
,These results were compared with the histological results in order to determine 
the accuracy of the clinical evaluation. This accuracy in the evaluation of the 
normal group was 80% for evaluator 1 and 60% for evaluator 2, but 20% - 40% 
of the specimens were categorized as possible lesion or lesion by the two 
evaluators. For this evaluation they did not have the opportunity to evaluate the 
tongues grossly, but only by observing images.  
0
2
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8
Evaluator 1
Evaluator 2
8 
6 
2 3 
0 1 
Normal Possible Lesion Lesion
Fig. 6 Clinical evaluation of Control group 
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The most substantial difference in the clinical evaluation was found in the treated 
group.  Evaluator 1 classified 18 as normal tongues while 21 were classified with 
possible lesions. The results of evaluator 2 contrasted with those of the first 
evaluator in that only 2 tongues were classified as normal while 12 were 
classified as possible lesion and 25 of the 39 specimens were categorized as 
having lesions (Fig. 7). 
 
The accuracy of this evaluation differed from the one obtained in the control 
group,  because more specimens were classified as having possible lesions and 
lesions. For this reason, two comparisons were made, the first evaluation 
between the normal vs. lesions and the second  corresponding to the evaluation 
of normal vs. possible lesions. Both evaluations were compared to the obtained 
histological sections. 
0
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Fig. 7 Clinical evaluation of Treated group 
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Histologic results demonstrated that 9 specimens of the treated group had no 
histological changes and were classified as normal, while 30  specimens 
presented some variations such as Hyperkeratosis, Hyperplasia with normal 
maturation, Hyperkeratosis with maturational disturbance and Maturational 
disturbance; all of these categories were grouped as lesion.   
Evaluator 1 was accurate in the identification of 3 treated tongues of 9 that were 
histologically diagnosed as normal while evaluator 2 identified correctly only 1 of 
the 9 tongues histologically classified as normal, but correctly identified 22 of 30 
as tongues with lesions (Fig. 8). 
 
The results of the evaluation of the specimens that were categorized by the 
evaluators as possible lesions were compared to the tongues histologically 
diagnosed with lesions. For evaluator 1, 15 tongues were selected as having a 
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possible lesion of a total of 30 that were  histologically  diagnosed with some 
changes that were considered as lesions, while evaluator 2 identified 7 tongues 
as having possible lesions. Both evaluators used the category “possible lesion” 
when they considered that the tongues were not normal but did not exhibit 
enough changes to be considered as tongues with lesion (Fig. 9). 
 
For the accuracy of the clinical evaluation of the treated group, evaluator 1 
correctly identified 30% of the tongues as normal while 50% of the tongues 
histologically diagnosed with lesions were  clinically identified as having possible 
lesions. Evaluator 2 correctly identified 1 specimen as normal, representing 11% 
of the diagnoses of the normal tongues. However, 29 tongues were identified as 
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Fig. 9 Clinical evaluation- Histological results, Normal vs Possible Lesion 
 23 
having possible lesions or lesions, representing 97% of the tongues with lesions 
(Fig. 10). 
 
OCT evaluation 
The results obtained from the two evaluations made by the two examiners were 
compared to the histological results obtained from the Department of Oral 
Pathology of the University of Connecticut Health Center. No histologic changes 
were noted in the control group as was expected, however only 30 specimens of 
the treated group showed some histological changes such as hyperkeratosis, 
Hyperkeratosis with maturational disturbance and only maturational disturbance. 
The most common changes noted in the specimens were hyperkeratosis 
followed by maturational disturbance (Figs. 11- 15).  
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Fig. 11. Histological (Panels a and b) and OCT( Panel c) images of the posterior aspect 
of a mouse tongue with hyperkeratosis (sacrificed on the 5th week of the experiment) 
Scale bars = 600 µm in (a) and 200 µm in (b).   
a                                                                       
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Fig. 12 Histological (Panels a and b) and OCT( Panel c) images of the middle aspect of 
a mouse tongue with hyperkeratosis (sacrificed on the 8th week of the experiment) 
Scale bars = 600 µm in (a) and 200 µm in (b).   
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Fig.13 Histological (Panels a and b) and OCT( Panel c) images of the middle aspect of a 
mouse tongue with crowding in the stratum spinosum (sacrificed on the 11th week of the 
experiment) Scale bars = 600 µm in (a) and 200 µm in (b).   
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Fig. 14 Histological (Panels a and b) and OCT( Panel c) images of the middle aspect of 
a mouse tongue with pleomorphism in the stratum spinosum (sacrificed on the 14 th 
week of the experiment) Scale bars = 600 µm in (a) and 200 µm in (b).   
 a 
b 
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Fig. 15 Histological image of the middle portion of a normal mouse tongue 
 (sacrificed on the 14th week) 
Scale bars = 600 µm in (a) and 200 µm in (b).   
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The evaluation of the OCT images showed a marked difference between the two 
evaluators. A week after the clinical evaluation was done, the evaluators 
classified the OCT images; these images were presented in a 15” screen. All the 
images were randomly inserted in a Keynote slideshow. The first four slides 
showed the OCT images with the histological sections of the same site; the 
remainder of the slideshow did not contain any histological sections. The order of 
the image presentation in the slideshow was different to avoid bias in the 
evaluations. 
The results obtained from Evaluator 1 for the two OCT evaluations of the control 
tongues were: in the first evaluation 10 of 10 were identified as normal and in the 
second evaluation only 9 tongues were accurately identified as normal while 1 
tongue was categorized as having a lesion. Evaluator two identified 7 tongues as 
normal, 2 as tongues with possible lesions and 1 with a lesion, while in the 
second evaluation 8 tongues were classified as normal and 2 as having possible 
lesions. The accuracy for the evaluation of the OCT images compared to the 
histological results was very high for both evaluators. For evaluator 1 the 
accuracy rate was 90-100% while for evaluator 2 the accuracy rate was 70-80% 
(Fig. 16). 
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Fig. 16 Evaluation of OCT images and histological results of control group 
 
For the  first evaluation of the tongues of the treated group, Evaluator 1 classified 
36 of the 39 tongues that were treated with 4NQO as normal, with no changes, 
while 3 were classified as having possible lesions. On the other hand, Evaluator 
2 considered that only 8 of the tongues of the treated group were normal and had 
no changes in the epithelium, while 18 were classified as having possible lesions 
and 13 had lesions.  
A week later the OCT evaluation was repeated, changing the order of the slides, 
and evaluating the same parameters. Evaluator 1 considered that 36  tongues 
had no changes and only 3 could have possible lesions. However, Evaluator 2 
classified 10 tongues as normal, 12 as having possible lesions and 17 were 
included in the group of tongues with lesions. According to the histological 
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evaluation 9 of 39 treated tongues had no histological changes and the rest had 
some changes and were classified as lesions (Fig. 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The accuracy of the results obtained in the evaluation of the treated group differs 
from the evaluation of the control group. Evaluator 1 was accurate in the 
identification of the tongues that had no changes. In the first evaluation 8 tongues 
were correctly identified and for the second evaluation 7 were selected as 
normal, however, no tongues were classified as tongues with lesions in both 
evaluations. Evaluator 2  identified 2 of the 9 tongues histologically diagnosed 
with no changes and in the second evaluation only 4 were identified as normal. 
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However, 10 tongues were correctly identified as having lesions in the first 
evaluation while 15 of the 30 tongues with lesions were identified in the second 
evaluation (Fig. 18). 
 
Many of the tongues that were evaluated in the treated group were classified as 
having possible lesions by both evaluators. The tongues that were included in the 
following results were those that were identified as having possible lesions with 
the OCT and histologically diagnosed with lesions. For  Evaluator 1, in the first 
evaluation, 2 tongues were classified as possible lesion while in the second 
evaluation 1 tongue was identified as having a possible lesion, Evaluator 2 
selected 14 specimens in the first evaluation as possible lesion while 9 were 
selected in the second evaluation (Fig. 19). 
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For accuracy of the treated group with histologically diagnosed lesions, evaluator 
1 correctly identified 3.33%- 6.66% of the tongues as having possible lesions 
while evaluator 2 correctly identified 30% and 46.66% of the tongues with lesions 
and 33.33% and 50% of the  specimens were identified as having possible 
lesions (Fig. 20). 
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Comparing the results obtained in the clinical and OCT evaluations, it is evident 
that the results of evaluator 1 were very consistent: in the normal group, 8 
tongues were identified as normal in the first evaluation with the OCT and 
classified in the same group in the clinical evaluation, while in the second 
evaluation 7 of the tongues were consistent with the clinical evaluation of the 
control group. For evaluator 2, however, in the clinical evaluation 6 tongues were 
included as normal, 3 as having a possible lesion and only one was defined as 
having a lesion. For this evaluator, only 3 tongues coincided with the clinical 
evaluation in the first evaluation with OCT,  and 4 tongues in the second 
evaluation (Fig. 21) 
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 Fig. 21 Comparison of Clinical and OCT Evaluation, Control group 
 
Comparison of the clinical evaluation and OCT images in the treated group 
differed from the results obtained in the control group. For evaluator 1, 18 
tongues were classified as normal in the clinical evaluation while 21 were 
considered as having a possible lesion. In the first evaluation with OCT, 17 
tongues were consistent with the normal diagnosis, and in the second evaluation 
with OCT, 18 tongues were considered as normal while three tongues were 
included as having a possible lesion or lesion. In contrast, evaluator 2 considered 
that only 2 tongues had a normal clinical appearance, 12 had a possible lesion 
and the remaining 25 had a lesion. In the first evaluation with OCT there was no 
constancy in the identification of normal tongues in the treated group, while a 
total of 16 tongues where included as having a possible lesion or lesion. In the 
second evaluation with OCT, only 1 specimen coincided with the clinical 
diagnosis as a normal tongue while 4 and 12 tongues were classified as having a 
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possible lesion or lesion, respectively (Fig. 22). The results of the evaluations are 
summarized in Table 1. 
Fig, 22 Comparison of Clinical - OCT evaluation, treated group 
 
 Categories 
Examiner 1 Examiner 2 
Histolog 
Results 
Clinic 
Eval 
OCT 
Eval 1 
 
OCT 
Eval 2 
Clinic 
Eval 
OCT 
Eval 1 
OCT 
Eval 2 
Control 
group 
Normal 8 10 9 6 7 8 10 
Possible 
lesion 
2 0 0 3 2 2 0 
Lesion 0 0 1 1 1 0 0 
Treated  
group 
Normal 18 36 36 2 8 10 9 
Possible 
lesion 
21 3 1 12 18 12 0 
Lesion 0 0 2 25 13 17 30 
 
Table 1. Results of Clinical and OCT evaluations and histological analysis 
 
0
7.5
15
22.5
30
Clinic. Eval
1 1 OCT Eval.
1 2 OCT Eval
1 Clinic. Eval
2 1 OCT Eval.
2 2 OCT Eval
2
18 
17 18 
2 
0 1 
21 
2 
1 
12 
7 
4 
0 0 2 
25 
9 12 
Normal Possible Lesion Lesion
 38 
STATISTICAL ANALYSIS 
Variables evaluated were: 1) presence or absence of the lesion, 2) changes in 
the thickness of the stratified squamous epithelial layer, 3) changes in the 
keratinized, stratified squamous epithelium. The presence of the lesion was rated 
as: No lesion, possible lesion and lesion present. The images of the control 
group were used as reference of the normal tissue.  Images obtained with the 
OCT resembled the architecture of the tissue evaluated in the  histopathologic 
exam, giving an indication of the structural changes as a consequence of the 
potentially malignant oral mucosal lesion. With the OCT it is difficult to try to 
identify precisely which cells are affected, compared to the histopathologic 
sections that provide a positive identification of the affected cells. 
Statistical analysis was performed utilizing the Kappa statistic, which is used 
when it is necessary to evaluate the results of physical exam findings, 
radiographic interpretations or other diagnostic tests, where the interpretation or 
diagnosis depends on the subjective interpretation of the evaluators. A Kappa of 
0 indicates the amount of agreement if the evaluators were simply guessing, and 
a Kappa of 1 indicates a perfect agreement 45. Based on the standard of this 
study K=0.6 was used as a good agreement. 
According to the Kappa statistics, when the clinical evaluation of Evaluator 1 was 
compared to the histological results, the result was K=0.0335 that means a slight 
level of agreement, compared to the result obtained for Evaluator 2 where 
K=0.4439 with a moderate level of agreement (Table 2). 
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Table 2. Results of the Kappa statistics 
 
When the OCT evaluation was compared to the histological results, the results 
obtained for Evaluator 1 were very different between the first evaluation with 
OCT, where K=0.055, and for the second evaluation, where K=-0.1125. There 
was a slight level of agreement for the first evaluation and none or negative 
agreement for the second evaluation. However, the results obtained by Evaluator 
2 demonstrated an increase of the level of agreement from slight to fair 
agreement. The results obtained were K=0.1874 for the first evaluation with OCT 
and K= 0.3905 for the second evaluation with OCT. 
Measure Weighted Kappa Level of 
agreement 
Evaluator 1 Clinic Eval. vs Histolog. results 0.0335 Slight 
Evaluator 1 OCT 1 Eval. vs Histolog. results 0.0055 Slight 
Evaluator 1 OCT 1 Eval vs Clinical Eval 0.0511 Slight 
Evaluator 1 OCT 2 Eval. vs Histolog. results -0.1125 None/negative 
Evaluator 1 OCT 2 Eval vs Clinical Eval 0.0855 Slight 
Evaluator 1 consistency 0.3691 Fair 
Evaluator 2 Clinic Eval. vs Histolog. results 0.4439 Moderate 
Evaluator 2 OCT 1 Eval. vs Histolog. results 0.1874 Slight 
Evaluator 2 OCT 1 Eval vs Clinical Eval 0.0982 Slight 
Evaluator 2 OCT 2 Eval. vs Histolog. results 0.3905 Fair 
Evaluator 2 OCT 2 Eval vs Clinical Eval 0.0983 Slight 
Evaluator 2 consistency 0.1062 Slight 
Inter-examiner Clinical Eval. consistency 0.0681 Slight 
Inter-examiner OCT 1 Eval. consistency -0.0035 None/negative 
Inter-examiner OCT 2 Eval. consistency 0.0179 Slight 
 40 
Results of the comparison between the  evaluation of the OCT  and the clinical 
evaluation were: for the first evaluation of Evaluator 1, K=0.0511 while the 
second evaluation of the OCT had a statistical result of K=0.0855, maintaining a 
slight level of agreement. The results obtained for the OCT evaluations and the 
clinical evaluation for Evaluator 2 were very consistent, for the first evaluation 
K=0.0982 while the second evaluation K=0.0983, with a slight level of agreement 
in both evaluations. 
The determinations  of the first evaluator were very consistent  with a K=0.3691, 
while Evaluator 2 had a slight consistency with K=0.1062. 
During this project, there was a slight consistency in the clinical evaluation 
between both examiners with K=0.0681. The consistency between the examiners 
for the OCT evaluations was quite different, while the K statistic for the first 
evaluation was negative with a value of -0.0035, the second evaluation was 
slightly  consistent with K=0.0179. 
Evaluator 1, in general, had a low rate of correct diagnoses, based on clinical 
and OCT evaluations, however was fairly self-consistent in the evaluation of the 
OCT images Evaluator 2 was moderately successful at correctly diagnosing 
lesions during the clinical evaluation but was not consistent with the evaluation of 
the OCT images. The level of agreement of both evaluators for their clinical 
evaluations vs. OCT evaluations was very low; the same results were obtained in 
the inter-examiner comparison 
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DISCUSSION 
 
In this study our aim was to demonstrate the efficacy of Optical Coherence 
Tomography to diagnose potentially malignant oral mucosal lesions of the 
tongue. The reason for investigating this topic is that the oral squamous cell 
carcinoma is frequently diagnosed in an advanced stage, and the survival rate 
may improve if it is diagnosed in an early stage. 
Screening based on visual and tactile examinations is recommended, which may 
result in early detection of oral cancer 12. The main objective of screening is to 
reduce mortality and morbidity from the disease by preventing progression of the 
lesion 46.  One of the recommendations reported in the literature is that dentists 
must perform an exhaustive clinical evaluation to find possible changes in areas 
such as the ventro-lateral aspect of the tongue, floor of the mouth and cheeks. 
These are the most frequent sites for oral squamous cell carcinoma, 
nevertheless more than 50% of oral cancers had spread to distant places of the 
body before they were originally diagnosed. This may suggest that many 
providers, or their patients or both, are either failing to recognize premalignant 
changes of the oral mucosa or the patients are evading clinical evaluation of 
these findings 47. 
In a survey conducted in 1998 by the National Health Interview Survey (NHIS), it 
was concluded that only 20.1% of American adults have ever received an oral 
cancer examination while other groups that include Afro-Americans, Hispanics 
and patients with low education were significantly less likely to have had such an 
examination. Another factor to be considered is the knowledge about oral cancer.   
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In a survey of American adults, 66%  to 85% responded that they had heard 
about oral cancer, nevertheless the majority of them did not know about oral 
cancer’s signs and symptoms, risk factors and oral cancer examination 48. 
Despite that some authors recommend the clinical evaluation, the criteria 
between evaluators may vary making successful early detection more 
challenging. In this project it was evident that of 39 mice that received the 
carcinogen agent, one evaluator considered that only 21 tongues showed 
possible clinical changes while the other evaluator considered that in 15 tongues 
possible changes were noted, and that 24 tongues had some premalignant 
changes. Nevertheless, 5 of the 10 tongues of the control group, that didn't 
receive any carcinogen agent in the drinking water, were evaluated as having a 
possible lesion or a lesion. Despite that the clinical evaluation is the exam most 
recommended by many clinicians it may have the potential to generate false 
positives and false negatives 49. Although it is important to continue to clarify the 
public health message and promote primary prevention, an important action that 
could help in the prevention of the oral cancer is determining the feasibility of a 
national screening program. Despite this strategy designed to enhance early 
detection of new cases, some authors consider that diagnosing early malignancy 
by only its visual appearance is not possible 49. 
A clinical evaluation must not be limited to the oral cavity. A physical examination 
is recommended, which must include evaluation of the head and neck, and 
exhaustive examination of the oral cavity, inspection and palpation of all mucosal 
surfaces, skin, scalp, tongue, hard and soft palate, dentition and cervical nodes18. 
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Some authors suggest that clinical evaluation has  limited value as a method for 
detecting potentially malignant lesions while others have reported that this 
examination has a high degree of sensitivity and specificity for detection of oral 
cancer 50. 
In this study there was a marked difference in the results obtained in the clinical 
evaluation of the specimens and the histological results. One of the evaluators 
was slightly precise in the identification especially for the specimens in the 
treated group, while the other examiner was moderately precise in the 
identification of the control and treated specimens. However, the results  
demonstrated that the clinical examination may vary between examiners. This 
kind of difference in the criteria may result in false positives or false negatives. 
Rethman stated that one of the limitations found in the clinical evaluation is that 
premalignant lesions often are asymptomatic and may mimic other conditions, 
whereas others may not be readily evident in routine examination. Also, because 
malignant and benign lesions may be clinically indistinguishable, the clinician 
cannot predict the biological relevance of lesions on the basis of their physical 
features alone 12. Another aspect to be considered is that oral cancer at an early 
stage is often dismissed as a traumatic or infective lesion 46. One of the largest 
challenges of the evaluation of oral diseases is the dilemma of attempting to 
predict which potentially malignant lesions will progress to neoplasia, notably oral 
squamous cell carcinoma (OSCC). It is difficult to find distinctive clinical features 
that differentiate benign, precancerous and early cancerous mucosal changes 16, 
51. 
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Many new techniques have been developed to aid the clinician in the screening 
of areas with possible premalignant lesions. Almost all of these techniques are 
non-invasive and this makes the patient feel more comfortable and less stressed 
with the screening. Some of these devices included in oral screening are: 
VELscope, Identafi, Narrow Band Imaging and OCT. 
The VELscope (LED Medical Diagnostics Inc, Barnaby, Canada) is used to 
excite endogenous fluorophores such as certain amino acids, metabolic products 
and structural proteins. Nevertheless, some authors argued that not all dysplastic 
lesions displayed loss of autofluorescence and its use could result in missed 
lesions and a false positive 36. 
Identafi (DentalEZ, PA, USA) is a multispectral screening device that has three 
different lights designed to be used  in a sequential manner to facilitate intraoral 
examination. With Identafi normal mucosa exhibits natural fluorescence, whereas 
abnormal tissues appear dark due to diminished autofluorescence. The ability to 
differentiate between low and high risk lesions is difficult with this device 36. 
Narrow Band Imaging (NBI; Olympus Medical Systems Corporation, Tokyo, 
Japan) is an endoscopic visualization technology which enhances the mucosal 
surface texture and underlying vasculature. NBI is based on the concept that the 
wavelength of light determines the depth of penetration, and that changes in the 
color of the superficial mucosa will be noted according to the extension of the 
lesions. With a magnification of approximately 1.5 times digital zoom, NBI has 
the potential to detect malignancies that might be missed with white light 36, 52.  
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Despite the diversity of screening devices, none of these replaces conventional 
visual and tactile examination of the oral soft tissues and are not diagnostic tests.  
None of these devices can effectively differentiate which lesion is considered a 
low risk or high risk 36, 46. It is important to recognize that the use of any visual aid 
is only an adjunct to the rigorous clinical evaluation of the head and neck and will 
never replace this important exam 51. 
Another diagnostic aid that has been used is the transepithelial cytology (Oral 
Cdx Brush Test, Suffern, NY). It consists of a disposable, circular plastic brush 
that the dentist or clinician rubs against the suspicious area until pinpoint 
bleeding is observed, confirming that the basement membrane was penetrated 
and a transepithelial sample was acquired. While the OralCDx BrushTest has 
demonstrated validity as an adjunct to lesion assessment in specific clinical 
situations, practitioners must remember that the diagnostic gold standard for oral 
cancers and potentially malignant lesions continues to be histopathological 
examination of surgical biopsy specimens 12, 46. 
Optical Coherence Tomography is a recently developed technique that has been 
used in areas of ophthalmology, dermatology, gynecology and recently in 
pulmonary, intravascular coronary and esophageal imaging. This high resolution 
imaging modality generates cross-sectional images with endogenous contrast 
based on variation in index of refraction. It has similar principles as ultrasound 
but with higher resolution 53. 
Comparison between OCT images and histopathology has been demonstrated in 
studies of both rats and humans, showing that OCT images could provide 
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microstructural information of malignant lesions 54. One of the advantages 
obtained with the use of the OCT is that this imaging technique reveals many 
detailed morphologic features of malignant and abnormal tissues,  that could be 
potentially significant local regions with high metabolic activities and early 
malignant changes 24. Some of the architectural changes that OCT is capable  of 
showing are: keratinized cell layer, epithelial layer, basement membrane, lamina 
propria and rete pegs of oral mucosa with the limitation that OCT does not 
provide any cellular information to grade the potentially malignant lesions 36. The 
resolution of the OCT is similar to low power microscopy, approximately 4X  53.  
Optical Coherence Tomography (OCT) has the potential to provide immediate 
and accurate diagnostic information, potentially reducing both the costs 
associated with unnecessary biopsies and treatment delays 36.  OCT can aid in 
guiding the clinician in the selection of the site to be biopsied, to ensure the 
precision of the affected area and to increase diagnostic yield of the biopsied 
tissue. It is recommended that the clinicians that will be using this imaging 
technique must be familiar with the normal conditions of the oral cavity in all 
aspects including clinical, histopathological and OCT imaging. The pathologist 
plays an important role in the development and implementation of OCT in clinical 
practice, using this technique as a complement to standard tissue pathology 53. 
However, in the present study the results obtained in the OCT evaluation were 
considerably different between the examiners. One of the evaluators was highly 
consistent with the classification of the specimens even though the final 
diagnosis was not consistent with the histological results. On the other hand, the 
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second examiner was moderately accurate in the classification of the specimens, 
however was self consistent with the evaluation.  
In contrast to the benefits of OCT referred to by many authors, potential 
disadvantages are the limited backscattering contrast between normal and 
dysplastic tissues, limited field of view and limitations in imaging depth 36. 
Another limitation of OCT is that it requires close proximity to the tissue being 
imaged to get cross-sectional, depth resolved images with micrometer-scale 
resolution without destruction or excision of the tissue 55. Although this technique 
is known by many authors as an optical biopsy, atypical cells are not 
distinguished in the OCT 56. However, the structural changes occurring in the 
different layers of the epithelium can be visualized in OCT images. Epithelial 
dysplasia is the most important predictor of malignant transformation and it can 
only be diagnosed with histological specimens 57.  
Regardless of all the advantages obtained with the use of all these new 
techniques, none of these devices can be considered as a replacement for the 
histological evaluation. While these devices may aid in the evaluation of the oral 
cavity, it is important that these devices not be used in the hands of 
inexperienced clinicians to avoid possible false positives or false negatives 57.  
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CONCLUSIONS 
Oral cancer is one of the most common types of cancer for which survival rates 
haven't improved in the last years. Dentists and clinicians must consider 
alternatives to be used to diagnose this disease in an early stage. 
The oral cancer screening examination must be part of the daily practice. It is 
recommended that every practitioner allow additional time to evaluate all the 
tissues of the oral cavity, head and neck. However, this valuable exam may yield 
variable results as in this study, in which clinical results differed widely between 
both examiners. It is important that the clinician must be familiar with the normal 
aspect of the oral tissues.  
Many devices are offered to help the clinician in the screening of oral 
malignancies. Despite the favorable results that manufacturers report, it is 
important to emphasize that none of the visual aid devices will substitute for the 
oral screening; these will be used as an adjunct to the clinical evaluation.  
OCT has been demonstrated to be an excellent evaluation aid that may be used 
to obtain information of the microstructural changes occurring in the oral 
epithelium; it is helpful to identify suspicious areas where a histological 
evaluation is recommended. The clinician must be familiar with the technique to 
avoid any false positives or false negatives. It is recommended to receive training 
in the use of the OCT, but most important is the necessity of knowing the normal 
aspect of the tissue visualized via OCT. 
Despite the fact that the images obtained with this high resolution imaging 
technique resemble the architecture of the different layers of the epithelium, it 
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has an important limitation: there is no information of the cellular changes 
occurring in the evaluated tissue, and for this reason it may not replace the 
histological evaluation  or biopsy. 
However, OCT is a valuable aid in the identification of microstructural changes 
occurring in the epithelial layers of the oral cavity, with an image quality similar to 
a low power microscope. This helps the clinician during the oral cancer 
screening, to obtain immediately multiplanar imaging sections of the evaluated 
area and 3D reconstruction of the area. Additionally, it may guide the clinician 
with the correct identification of an affected area to be biopsied. 
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FUTURE DIRECTIONS 
For future studies it is recommended that additional examiners participate in the 
evaluation of the images obtained in the present study, including specialists in 
the different areas of dentistry that participate in the screening of patients. 
Another aspect to consider in future evaluations is the use of a handheld OCT 
device to be used in vivo in the oral cavity. 
 A similar study is recommended to evaluate architectural changes of the 
epithelial layers of the oral cavity from early stage to an advanced stage of oral 
squamous cell carcinoma.  
Additionally, it is recommended that other hard components of the tooth, such as 
enamel and dentin, be examined to evaluate the accuracy of the OCT in the 
diagnosis of incipient caries. 
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